StemCell Therapy

LONDON–(BUSINESS WIRE)– DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that it has licensed its ground-breaking Genalysis technology platform for rapid, lab-free DNA detection to geneOnyx, a company that is delivering on-the-spot genetic analytics services for cosmetics and skincare applications. Following a successful evaluation of the DNA Electronics USB-based Genalysis lab-free platform, the two companies are announcing a commercial license and supply agreement that grants geneOnyx access to DNA Electronics real-time Genalysis platform for cosmetic applications.

ScienceDaily (Mar. 16, 2012) Scientists at the University of Toronto have found a molecular mechanism that plays a key role in the transition of Candida albicans yeast into disease-causing fungus — one of the leading causes of hospital-acquired infection. The finding highlights the importance of heat in fungal growth, and provides a new target for drug therapies to counter Candida albicans infection

Scientists at the University of Toronto have found a molecular mechanism that plays a key role in the transition of Candida albicans yeast into disease-causing fungus-one of the leading causes of hospital-acquired infection. The finding highlights the importance of heat in fungal growth, and provides a new target for drug therapies to counter Candida albicans infection. Candida albicans is a normally harmless yeast that is present in all humans

Public release date: 16-Mar-2012 [ | E-mail | Share ] Contact: Jim Oldfield jim.oldfield@utoronto.ca 416-946-8423 University of Toronto TORONTO, ONScientists at the University of Toronto have found a molecular mechanism that plays a key role in the transition of Candida albicans yeast into disease-causing fungusone of the leading causes of hospital-acquired infection.

By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) Dealing with incidental findings uncovered in whole-genome and whole-exome sequencing studies has been a contentious issue in the move to bring next-generation sequencing into the clinic. A paper published today in Genetics in Medicine finds that physicians generally agree that those findings should be returned to adult patients, especially when medical intervention is possible.

MANILA, Philippines – A forum on toxic chemicals present in beauty products was held yesterday by the Food and Drug Administration (FDA) and the Eco Waste Coalition at the FDA compound in Muntinlupa City.

Vanity can pose dangers to mens health, too. While women are most vulnerable to hazardous substances due to constant use of beauty products, men are also exposed to as many as 80 chemicals daily from personal care items such as soap, shampoo, shaving cream and perfume after shave, according to Ann Blake, a California-based molecular genetics expert.

COPENHAGEN, Denmark, March 12, 2012 /PRNewswire/ — The Grete Lundbeck European Brain Research Foundation announced today that The Brain Prize 2012 is jointly awarded to Christine Petit and Karen Steel: ‘for their unique, world-leading contributions to our understanding of the genetic regulation of the development and functioning of the ear, and for elucidating the causes of many of the hundreds of inherited forms of deafness.’ Inherited conditions render one in a thousand children deaf at birth, and cause as many again to become deaf before maturity, leading to delay or failure in the acquisition of speech, and frequently to disadvantages in communication and learning. Genetic anomalies also contribute to many age-related and progressive forms of hearing loss

Featured Article Academic Journal Main Category: Genetics Also Included In: Psychology / Psychiatry;Neurology / Neuroscience;Veterinary Article Date: 09 Mar 2012 – 8:00 PST email to a friend printer friendly opinions Current Article Ratings: They begin their report by saying we know little about the molecular basis of the differences in behavior among individuals. One behavior that interests many scientists that study insects, is that of honey bee scouts

By Ben Butkus Abbott and Dallas-based Genetics Laboratory are co-developing a molecular test designed to rapidly detect microorganisms that cause orthopedic infections, Abbott said this week.

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/aa887c/molecular_diagnost) has announced the addition of the “Molecular Diagnostics: Market Segmentation and Opportunities – 4th Edition” report to their offering.

OUTSTANDING RESEARCHER OF THE YEAR, $50,000 AWARD Roger Reddel Director, Children’s Medical Research Institute (CMRI) PROFESSOR Roger Reddel is a cancer research pioneer. He leads the CMRI’s Cancer Research Unit, a team of 15 scientists who have made significant breakthroughs focusing on cancer molecular genetics over the past two decades. The breakthroughs have been in the area of ”immortalisation”, in which some cancer cells continue to divide an infinite number of times

Newswise DALLAS March 6, 2012 Dr.

Public release date: 6-Mar-2012 [ | E-mail | Share ] Contact: Deborah Wormser deborah.wormser@utsouthwestern.edu 214-648-3404 UT Southwestern Medical Center DALLAS March 6, 2012 Dr. Eric Olson, founding chairman of the molecular biology department at UT Southwestern Medical Center, has won the 2012 Passano Award for identifying major genetic pathways that control the development of the heart and other muscles

Japan’s National Institute of Genetics has selected one of SGI’s supercomputing systems to meet its next-generation sequence data analysis needs. SGI said that the research organization selected an SGI UV1000 system, which includes 768 processor cores and 10 terabytes of memory

By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) Breast cancer diagnostics developer Atossa Genetics said today that its breast health reference lab has received Clinical Laboratory Improvement Amendments certification from the Centers for Medicare and Medicaid Services. The company’s National Reference Laboratory for Breast Health subsidiary, located in Seattle, was certified after an inspection of its facilities, processes, and personnel, and a review of the validation and clinical reports from its lab-developed tests, and the ForeCyte and ArgusCyte Breast Health Tests. The company’s tests use molecular and cellular biomarkers for breast cancer risk, and are based on its Mammary Aspirate Specimen Cytology system, which enables nurses or physician assistants to collect samples in around 10 minutes.

ABBOTT PARK, Ill., March 5, 2012 /PRNewswire/ –Abbott(NYSE: ABT – News) announced today it will collaborate with Genetics Laboratory, Inc. (GenLab) on the development of a molecular diagnostic test that will be designed to rapidly detect microorganisms that cause orthopedic infections. Under terms of the agreement, Abbott, in conjunction with GenLab, will develop and commercialize the new assay for use on the PLEX-ID automated microbial identification system.

Public release date: 1-Mar-2012 [ | E-mail | Share ] Contact: Erin Pope Erin.Pope@NationwideChildrens.org 614-355-0495 Nationwide Children’s Hospital In 2010, the Center for Gene Therapy at Nationwide Children’s Hospital launched a monthly podcast entitled, “This Month in Muscular Dystrophy,” featuring internationally known scientists discussing the latest research in muscular dystrophy and other neuromuscular disorders. Now, these podcasts will be available for users on iTunes and at www.NationwideChildrens.org/muscular-dystrophy-podcast. The podcasts are geared toward patients, their families and primary care physicians who take care of patients with neuromuscular diseases.

SEATTLE–(BUSINESS WIRE)– Natural Molecular Testing Corp. (NMTC), a company providing groundbreaking clinical molecular testing and services in the medical genomics field, today announced that Karthikeshwar Kasirajan, M.D., has joined the company as Chief Medical Officer

PALO ALTO, Calif.–(BUSINESS WIRE)– Cancer Commons, an openscience initiative to personalize cancer treatments and accelerate research, announces the publication of a molecular disease model (MDM) for lung cancer. The paper, by Lisandra West, Ravi Salgia, and others will appear in the February 21st issue of PLoS ONE (http://www.plosone.org)